Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Limited announced that the Hon'ble National Company Law Tribunal (NCLT), Bengaluru Bench, has sanctioned the Scheme of Arrangement between its wholly owned subsidiary, NH Integrated Care Private Limited, and Narayana Hrudayalaya Limited. The scheme, effective from April 1, 2025, involves the demerger of the Clinical Services undertaking of the subsidiary, including 9 clinics in Bengaluru and 1 in Hosur, into Narayana Hrudayalaya Limited on a going-concern basis. As the subsidiary is wholly owned, no new shares will be issued, and there will be no change in the company's share capital or shareholding pattern. The Scheme becomes effective upon filing the certified copy of the order with the Registrar of Companies.

Narayana Hrudayalaya Limited reported a strong Q2 FY27 with consolidated operating revenue surging 73.0% year-on-year to ₹28,440 Mn, largely driven by the UK acquisition. EBITDA grew 42.0% YoY to ₹6,054 Mn, and PAT increased 16.6% YoY to ₹3,012 Mn. Excluding the UK, revenue grew 22.6% YoY, with India revenue up 16.6% YoY due to higher patient volumes and complex procedures. The company expanded its capacity with new hospital openings and additions to its pipeline, targeting over 7,800 beds. The net debt to equity ratio improved to 0.38 from 0.42. Management expressed confidence in achieving yearly expectations.

Narayana Hrudayalaya Ltd has announced the appointment of M/s. B S R & Co. LLP, Chartered Accountants, as its new Statutory Auditors. This appointment, approved by the Board of Directors based on the Audit Committee's recommendation, is for a term of five consecutive years, commencing from the conclusion of the 27th Annual General Meeting (AGM) in 2027 until the conclusion of the 32nd AGM in 2032. The appointment is subject to shareholder approval at the upcoming 27th AGM. The current auditors, M/s. Deloitte Haskins & Sells LLP, will retire upon completion of their second five-year term at the 27th AGM in 2027, as they are not eligible for re-appointment under Section 139(2) of the Companies Act, 2013. B S R & Co. LLP is a well-established firm with extensive experience auditing listed companies, including those in the healthcare sector.

Narayana Hrudayalaya Ltd has announced that its Board of Directors will convene on October 30, 2026. The primary agenda item for this meeting is to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. This disclosure is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will also make this information available on its official website.

Narayana Hrudayalaya Ltd has announced the commencement of commercial operations for its new hospital, KS-Narayana Hospital, located in Banashankari, Bengaluru. The hospital, which has a capacity of 110 beds, began operations on October 5, 2026. This development aligns with the company's previously indicated timeline of FY 2026-27. The hospital is operated and managed by Narayana Hrudayalaya under an Operation and Management Agreement with M/s. Kammavari Sangham.

Narayana Hrudayalaya Ltd has entered into an Operation and Management Agreement with Mission of Mercy Hospital and Research Centre and The Assemblies of God of North India. The agreement appoints Narayana Hrudayalaya to exclusively operate, manage, direct, and control the Mission of Mercy Hospital & Research Centre in Kolkata. This leverages the company's expertise in healthcare management to support the hospital's sustainability and operations. The hospital comprises approximately 63,240 sq. ft. with a 100-bed capacity. The commencement of operations is subject to certain conditions precedent, which may take up to 12 months.

Narayana Hrudayalaya Ltd has received an Order-in-Original from the Assistant Commissioner of Central Tax, Bengaluru, imposing a GST demand of ₹53,15,150/- along with applicable interest and penalty. The demand pertains to GST on corporate guarantees provided by the company to its subsidiaries for the period April 2021 to October 2023. The company states there is no material impact on its financials or operations and intends to appeal the order. The delay in disclosure was attributed to an inadvertent internal communication gap.

Narayana Hrudayalaya Limited has announced the closure of its trading window for all insiders, including directors and designated persons, effective October 01, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The trading window will remain shut until 48 hours after the declaration of the unaudited financial results for the quarter ending September 30, 2026. The specific date for the board meeting to approve these results will be communicated later.

Narayana Hrudayalaya Ltd. announced a change in its corporate office address, effective September 21, 2026. The corporate office will move from its existing location at Bommasandra Industrial Area to 8th & 9th Floor, No. 84, Phase 1, West Avenue - 1, Electronics City, Bengaluru – 560100. The company clarified that its registered office address remains unchanged at 258/A, Bommasandra Industrial Area, Anekal Taluk, Bengaluru – 560099. This intimation is in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Narayana Hrudayalaya Ltd announced its Q1 FY27 financial results, reporting a consolidated operating revenue of ₹26,836 Mn, marking a significant 78.0% year-on-year growth. Consolidated EBITDA stood at ₹5,052 Mn, up 40.0% YoY, with a margin of 18.8%. Consolidated PAT increased by 5.7% YoY to ₹2,073 Mn. India's operating revenue grew 17.0% YoY, while Cayman's revenue saw a 38.9% YoY increase. The newly acquired UK business contributed ₹8,257 Mn. Management noted strong performance across all geographies, driven by increased patient footfall, focus on complex procedures, and successful integration of the UK operations.